Ozempic Linked to Reduced Risk of Stroke and Alzheimer's by Up to 49%
Audio narration · Coming soon
A new genetic study suggests that GLP-1 drugs like Ozempic may provide benefits beyond diabetes and weight loss. The research indicates these medications could lower the risk of stroke and Alzheimer's disease by up to 49%. This finding highlights potential broader therapeutic uses for GLP-1 drugs.
Why this matters
PRISM scored this story 65/100 for interest.
Originally published by gnews